BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

SAGE Therapeutics 

29 Newbury Street

Boston  Massachusetts  02116  U.S.A.
Phone: n/a Fax: n/a


SEARCH JOBS




Industry
Pharmaceutical

Segment
Start Up





 Company News
SAGE Therapeutics Reports Third Quarter 2014 Results 11/11/2014 8:47:19 AM
SAGE Therapeutics Reports Positive Top-Line Phase 2 Data of SAGE-547 in Patients With Super-Refractory Status Epilepticus 11/10/2014 6:45:17 AM
MA Startup SAGE Therapeutics' Drug For Rare Epilepsy Shows Promise In Small Study 11/10/2014 6:44:06 AM
SAGE Therapeutics Announces Six Scientific Presentations At Neuroscience 2014, The Society For Neuroscience's 44th Annual Meeting 11/7/2014 12:12:19 PM
SAGE Therapeutics To Present At Credit Suisse 23rd Annual Healthcare Conference 11/5/2014 10:11:40 AM
SAGE Therapeutics Release: First Evaluation Of SAGE-547 To Treat Super-Refractory Status Epilepticus In Children Published In Annals Of Neurology 11/3/2014 8:31:38 AM
SAGE Therapeutics Initiates Exploratory Study Of SAGE-547 In Essential Tremor 10/23/2014 7:27:19 AM
SAGE Therapeutics To Participate In The 2014 Leerink Partners Rare Disease Roundtable 9/25/2014 7:42:13 AM
SAGE Therapeutics Appoints Michael F. Cola To The Company's Board Of Directors 9/16/2014 12:51:30 PM
SAGE Therapeutics Presents New Preclinical Data On SAGE-217 At Eilat Conference On New Anti-Epileptic Drugs 9/2/2014 1:47:41 PM
12345